SE448237B - 8-aminoalkyl-4-alkylpsoralener, forfarande for deras framstellning samt farmaceutisk komposition, vilken sasom aktiv komponent innehaller nemnda foreningar - Google Patents
8-aminoalkyl-4-alkylpsoralener, forfarande for deras framstellning samt farmaceutisk komposition, vilken sasom aktiv komponent innehaller nemnda foreningarInfo
- Publication number
- SE448237B SE448237B SE8006294A SE8006294A SE448237B SE 448237 B SE448237 B SE 448237B SE 8006294 A SE8006294 A SE 8006294A SE 8006294 A SE8006294 A SE 8006294A SE 448237 B SE448237 B SE 448237B
- Authority
- SE
- Sweden
- Prior art keywords
- lower alkyl
- psoralen
- methyl
- preparation
- aminomethylpsoralen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 150000001875 compounds Chemical class 0.000 claims description 21
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N furocoumarin Natural products C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 9
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 claims description 8
- -1 alkyl psoralen Chemical compound 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 4
- 230000002215 photochemotherapeutic effect Effects 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000002165 photosensitisation Effects 0.000 description 9
- 125000000217 alkyl group Chemical group 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- FMHHVULEAZTJMA-UHFFFAOYSA-N trioxsalen Chemical compound CC1=CC(=O)OC2=C1C=C1C=C(C)OC1=C2C FMHHVULEAZTJMA-UHFFFAOYSA-N 0.000 description 4
- 241000700198 Cavia Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000003504 photosensitizing agent Substances 0.000 description 3
- 150000003194 psoralenes Chemical class 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- CWBNOQSQEHMTNZ-UHFFFAOYSA-N 4,8-dimethyl-7-prop-2-enoxychromen-2-one Chemical compound CC1=C(OCC=C)C=CC2=C1OC(=O)C=C2C CWBNOQSQEHMTNZ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010058667 Oral toxicity Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 231100000418 oral toxicity Toxicity 0.000 description 2
- 208000017983 photosensitivity disease Diseases 0.000 description 2
- 231100000434 photosensitization Toxicity 0.000 description 2
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960000850 trioxysalen Drugs 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- WBIICVGYYRRURR-UHFFFAOYSA-N 3-(aminomethyl)-2,5,9-trimethylfuro[3,2-g]chromen-7-one Chemical compound O1C(=O)C=C(C)C2=C1C(C)=C1OC(C)=C(CN)C1=C2 WBIICVGYYRRURR-UHFFFAOYSA-N 0.000 description 1
- MVMMGVPSTRNMSV-UHFFFAOYSA-N 7-hydroxy-4,8-dimethylchromen-2-one Chemical compound CC1=C(O)C=CC2=C1OC(=O)C=C2C MVMMGVPSTRNMSV-UHFFFAOYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical group C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000006698 hydrazinolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- DFMAXQKDIGCMTL-UHFFFAOYSA-N isopimpinellin Chemical compound O1C(=O)C=CC2=C1C(OC)=C1OC=CC1=C2OC DFMAXQKDIGCMTL-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000010512 small scale reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/073,907 US4269851A (en) | 1979-09-10 | 1979-09-10 | 8-Aminoalkyl-4-alkylpsoralens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8006294L SE8006294L (sv) | 1981-03-11 |
| SE448237B true SE448237B (sv) | 1987-02-02 |
Family
ID=22116511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8006294A SE448237B (sv) | 1979-09-10 | 1980-09-09 | 8-aminoalkyl-4-alkylpsoralener, forfarande for deras framstellning samt farmaceutisk komposition, vilken sasom aktiv komponent innehaller nemnda foreningar |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4269851A (en, 2012) |
| JP (1) | JPS5645479A (en, 2012) |
| AT (1) | AT373258B (en, 2012) |
| AU (1) | AU532763B2 (en, 2012) |
| BE (1) | BE885156A (en, 2012) |
| CA (1) | CA1141766A (en, 2012) |
| CH (1) | CH644864A5 (en, 2012) |
| DE (1) | DE3033895A1 (en, 2012) |
| FR (1) | FR2464957A1 (en, 2012) |
| GB (1) | GB2058073B (en, 2012) |
| IE (1) | IE50160B1 (en, 2012) |
| IT (1) | IT1132695B (en, 2012) |
| NL (1) | NL8005081A (en, 2012) |
| SE (1) | SE448237B (en, 2012) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4370344A (en) * | 1979-09-10 | 1983-01-25 | Elder Pharmaceuticals, Inc. | 5'-Aminoalkyl-4'-alkylpsoralens |
| US4328239A (en) * | 1979-09-10 | 1982-05-04 | Elder Pharmaceuticals, Inc. | 8-Aminoalkylpsoralens |
| US5116864A (en) * | 1991-04-09 | 1992-05-26 | Indiana University Foundation | Method for preventing restenosis following reconfiguration of body vessels |
| US5399719A (en) * | 1993-06-28 | 1995-03-21 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
| US5556993A (en) | 1993-06-28 | 1996-09-17 | Steritech, Inc. | Compounds for the photodecontamination of pathogens in blood |
| US6004742A (en) * | 1993-06-28 | 1999-12-21 | Cerus Corporation | Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens |
| US6004741A (en) * | 1993-06-28 | 1999-12-21 | Cerus Corporation | Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations |
| US5871900A (en) * | 1993-06-28 | 1999-02-16 | Cerus Corporation | Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens |
| US5593823A (en) * | 1993-06-28 | 1997-01-14 | Cerus Corporation | Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens |
| US6420570B1 (en) | 1993-06-28 | 2002-07-16 | Cerus Corporation | Psoralen compounds |
| US5691132A (en) * | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
| US6177441B1 (en) | 1995-06-05 | 2001-01-23 | Cerus Corporation | Treating red blood cell solutions with anti-viral agents |
| DE69819360T2 (de) * | 1997-11-20 | 2004-08-19 | Cerus Corp., Concord | Neue psoralene zur inaktivierung von pathogenen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH614957A5 (en, 2012) * | 1976-05-28 | 1979-12-28 | Fotobio Holding Ag | |
| US4169204A (en) * | 1976-10-20 | 1979-09-25 | Regents Of The University Of California | Psoralens |
| US4124598A (en) * | 1976-10-20 | 1978-11-07 | Hoffmann-La Roche Inc. | Psoralens |
-
1979
- 1979-09-10 US US06/073,907 patent/US4269851A/en not_active Expired - Lifetime
-
1980
- 1980-08-09 IE IE1891/80A patent/IE50160B1/en unknown
- 1980-09-08 IT IT24520/80A patent/IT1132695B/it active
- 1980-09-09 CA CA000359872A patent/CA1141766A/en not_active Expired
- 1980-09-09 FR FR8019451A patent/FR2464957A1/fr active Granted
- 1980-09-09 DE DE19803033895 patent/DE3033895A1/de active Granted
- 1980-09-09 NL NL8005081A patent/NL8005081A/nl not_active Application Discontinuation
- 1980-09-09 GB GB8029145A patent/GB2058073B/en not_active Expired
- 1980-09-09 AT AT0453780A patent/AT373258B/de not_active IP Right Cessation
- 1980-09-09 SE SE8006294A patent/SE448237B/sv not_active IP Right Cessation
- 1980-09-09 AU AU62170/80A patent/AU532763B2/en not_active Ceased
- 1980-09-09 BE BE0/202046A patent/BE885156A/fr not_active IP Right Cessation
- 1980-09-10 CH CH680880A patent/CH644864A5/de not_active IP Right Cessation
- 1980-09-10 JP JP12474380A patent/JPS5645479A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE801891L (en) | 1981-03-10 |
| GB2058073B (en) | 1983-06-08 |
| IT8024520A0 (it) | 1980-09-08 |
| BE885156A (fr) | 1980-12-31 |
| CH644864A5 (de) | 1984-08-31 |
| GB2058073A (en) | 1981-04-08 |
| FR2464957A1 (fr) | 1981-03-20 |
| AT373258B (de) | 1984-01-10 |
| CA1141766A (en) | 1983-02-22 |
| FR2464957B1 (en, 2012) | 1982-12-03 |
| DE3033895C2 (en, 2012) | 1989-04-20 |
| IE50160B1 (en) | 1986-02-19 |
| ATA453780A (de) | 1983-05-15 |
| AU6217080A (en) | 1981-03-19 |
| AU532763B2 (en) | 1983-10-13 |
| NL8005081A (nl) | 1981-03-12 |
| IT1132695B (it) | 1986-07-02 |
| DE3033895A1 (de) | 1981-04-02 |
| JPS5645479A (en) | 1981-04-25 |
| SE8006294L (sv) | 1981-03-11 |
| US4269851A (en) | 1981-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4296039A (en) | Selected process for producing monohalogenated derivatives of 7-hydroxy-coumarin | |
| SE448237B (sv) | 8-aminoalkyl-4-alkylpsoralener, forfarande for deras framstellning samt farmaceutisk komposition, vilken sasom aktiv komponent innehaller nemnda foreningar | |
| US4294822A (en) | 5-Aminoalkyl-4,4,8-trialkylpsoralens | |
| Lin et al. | Potential bioreductive alkylating agents. 5. Antineoplastic activity of quinoline-5, 8-diones, naphthazarins, and naphthoquinones | |
| IE51692B1 (en) | Furocoumarin compositions | |
| US4298614A (en) | 5'-Aminoalkyl-4',4-dialkylpsoralens | |
| US4269852A (en) | 4'-Substituted-4,5',8-trialkylpsoralens | |
| RU2282627C2 (ru) | Кумариновые производные с подавляющей комт активностью | |
| NO151500B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazoloksamsyre-derivater | |
| US4328239A (en) | 8-Aminoalkylpsoralens | |
| Gillespie et al. | Benzimidazoles and benzotraizoles as growth antagonists | |
| US4279922A (en) | Photosensitizing benzofuranacrylics | |
| O'BRIEN et al. | Amino derivatives of Kojic acid | |
| Buu-Hoï et al. | A synthesis of methyl homologues of naphthols and dihydroxynaphthalenes | |
| Buu-Hoï | 431. The chemistry of carcinogenic nitrogen compounds. Part V. Angular hydroxybenzacridines and hydroxydibenzacridines | |
| JPH10203977A (ja) | 抗腫瘍剤 | |
| JP2546687B2 (ja) | リン酸ジエステルまたはその塩からなる抗酸化剤 | |
| SE466104B (sv) | Nya triazolpyrimidiner och foerfarande foer deras framstaellning | |
| US3798240A (en) | 3-(hydroxymethyl)chromones | |
| Cohen et al. | Synthesis of 2‐amino‐5, 6‐dihydro‐4H‐1, 3‐thiazines and related compounds by acid catalyzed cyclization of allylic isothiuronium salts | |
| WO1998022468A1 (en) | Psoralen sensitizers for viral inactivation | |
| JPH0129794B2 (en, 2012) | ||
| US4994469A (en) | Diaclyl-substituted methylene-2,2,4-trimethyl-1,2-dihydroquinolines and a process for the preparation thereof | |
| Benson et al. | 5, 6-Dimethylbenzotriazole and its acyl derivatives | |
| US1963471A (en) | Nicotine salts of 2.4-dinitrophenol and substituted derivatives thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8006294-6 Effective date: 19900703 Format of ref document f/p: F |